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Approximately 8 to 12 million people in the United States suffer from peripheral artery disease (PAD). PAD 
causes narrowed arteries and reduces blood flow to the lower extremities. People with PAD begin to experience 
discomfort and pain while walking. Untreated PAD can lead to ulcers, gangrene, and amputation. Before 
experiencing those severe conditions, detection of narrowing blood vessel enables early diagnosis and 
treatment. Therefore, accurate and timely diagnosis is necessary.  
We have developed a low-cost wearable imaging band system that employs dynamic diffuse optical 
spectroscopy (dDOS) technique. The system includes 4 different measurement modules that each has a pair of 
three light-sources and a single Si-photodetector. The three light-source consists of light emitting diodes (LEDs) 
operating at wavelengths of 530, 655, 940 nm. When an individual light source is on, four detectors at different 
spots around a toe read the intensities of diffusely reflected and transmitted light. The intensity of light is 
converted to a voltage and amplified by transimpedance amplifier (TIA). The digitized data is transferred to a 
computer by microcontroller and embedded system.  
We have used the system in a clinical pilot study with 10 PAD patients that undergo an endovascular 
intervention. The wearable imaging band accesses PAD patients 1 hour before and 1 hour after angioplasty. 
Thigh pressure cuff occlusions at 60 
mmHg and 100 mmHg are applied for 60 
seconds each, and the changes in light 
transmission are recorded. During the 
thigh cuff occlusion, the blood volume in 
the extremities is changed leading to a 
change in the measured signal. An 
example for a patient whose medial plantar 
artery (MPA) was treated is shown in 
Figure 1. The wearable imaging band 
wrapped around the patient`s toe is shown 
in Figure 1 (a). Figure 1 (b), (c), and (d) 
show absorbance changes of wavelengths 
at 530, 655, and 940 nm respectively 
during a100 mmHg occlusion. Absorbance 
before angioplasty (dotted line) reaches 
the max value more slowly than after 
receiving an angioplasty (solid line). We 
hypothesize that in untreated patients the 
narrowed MPA can only respond slowly to 
the cuff. The treated MPA has a larger 
lumen and hence the blood pooling in a 
toe increases much faster during thigh 
occlusion. Similar results were found in all 
10 patients. 
We have shown that the wearable imaging 
band system can detect differences 
between hemodynamics before and after 
angioplasty. The wearable form factor 
should allow for integration in home-based monitoring systems, where it could potentially be used to assess the 
status of the vasculature. Therefore, early diagnosis and monitoring of PAD in daily life may be possible. 
Figure 1. Wearable imaging band wrapped around a toe (a) 
and change of absorbance of three wavelengths (530 nm(b) , 
655 nm (c), 940 nm (d)), measured before and after 
angioplasty at a thigh cuff occlusion of 100 mmHg from 
Peripheral Artery Disease (PAD) patient. 
 
